1,277 results on '"Büller, Harry R."'
Search Results
2. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study
3. Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study
4. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism
5. Novel insights into weight loss: acupuncture combined with a very low-carbohydrate diet—a Swiss experience
6. Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis
7. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis
8. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy
9. Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
10. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study
11. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis
12. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
13. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
14. Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)
15. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
16. Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
17. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
18. Upper Extremity Deep Vein Thrombosis
19. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis.
20. Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus
21. Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism
22. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data
23. Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis
24. Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis
25. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups: A Systematic Review and Individual-Patient Data Meta-analysis
26. Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis
27. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups
28. Long-term Risk of Recurrent Venous Thromboembolism Among Patients Receiving Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
29. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
30. Knowledge of the D-dimer test result influences clinical probability assessment of pulmonary embolism
31. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism
32. Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
33. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
34. von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation
35. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
36. Whole-Arm Ultrasound for Suspected Upper-Extremity Deep Venous Thrombosis in Outpatients
37. Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1–mediated vascular endothelial barrier enhancement
38. Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care
39. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial
40. Factor XI Antisense Oligonucleotide for Venous Thrombosis
41. Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
42. Abelacimab for Prevention of Venous Thromboembolism
43. Prenatal exposure to the Dutch famine is associated with a preference for fatty foods and a more atherogenic lipid profile
44. The Importance of Clinical Probability Assessment in Interpreting a Normal d-Dimer in Patients With Suspected Pulmonary Embolism
45. A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
46. Challenges in the Diagnosis Acute Pulmonary Embolism
47. Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
48. Acute pulmonary embolism. Part 2: treatment
49. Acute pulmonary embolism. Part 1: epidemiology and diagnosis
50. Alternative diagnoses in patients in whom the GP considered the diagnosis of pulmonary embolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.